IL309983A - Antibody competition model using latent variable affinity - Google Patents

Antibody competition model using latent variable affinity

Info

Publication number
IL309983A
IL309983A IL309983A IL30998324A IL309983A IL 309983 A IL309983 A IL 309983A IL 309983 A IL309983 A IL 309983A IL 30998324 A IL30998324 A IL 30998324A IL 309983 A IL309983 A IL 309983A
Authority
IL
Israel
Prior art keywords
affinities
antibody competition
hidden variables
competition model
model
Prior art date
Application number
IL309983A
Other languages
English (en)
Hebrew (he)
Original Assignee
Abcellera Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abcellera Biologics Inc filed Critical Abcellera Biologics Inc
Publication of IL309983A publication Critical patent/IL309983A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/30—Drug targeting using structural data; Docking or binding prediction
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Theoretical Computer Science (AREA)
  • Biotechnology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Evolutionary Computation (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Bioethics (AREA)
  • Software Systems (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Artificial Intelligence (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
IL309983A 2021-07-08 2022-07-08 Antibody competition model using latent variable affinity IL309983A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163219578P 2021-07-08 2021-07-08
PCT/US2022/036517 WO2023009293A2 (en) 2021-07-08 2022-07-08 Antibody competition model using hidden variable affinities

Publications (1)

Publication Number Publication Date
IL309983A true IL309983A (en) 2024-03-01

Family

ID=84785421

Family Applications (1)

Application Number Title Priority Date Filing Date
IL309983A IL309983A (en) 2021-07-08 2022-07-08 Antibody competition model using latent variable affinity

Country Status (11)

Country Link
US (1) US20250364074A1 (https=)
EP (1) EP4367676A2 (https=)
JP (1) JP2024526314A (https=)
KR (1) KR20240025697A (https=)
CN (1) CN117882137A (https=)
AU (1) AU2022320541A1 (https=)
CA (1) CA3225236A1 (https=)
GB (1) GB2623274A (https=)
IL (1) IL309983A (https=)
MX (1) MX2024000443A (https=)
WO (1) WO2023009293A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117334247B (zh) * 2023-10-12 2025-07-08 北京百度网讯科技有限公司 抗原抗体亲和力预测模型的训练方法和抗体筛选方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8706421B2 (en) * 2006-02-16 2014-04-22 Microsoft Corporation Shift-invariant predictions

Also Published As

Publication number Publication date
CA3225236A1 (en) 2023-02-02
WO2023009293A9 (en) 2023-04-06
US20250364074A1 (en) 2025-11-27
GB202401655D0 (en) 2024-03-20
MX2024000443A (es) 2024-03-13
GB2623274A (en) 2024-04-10
JP2024526314A (ja) 2024-07-17
KR20240025697A (ko) 2024-02-27
AU2022320541A1 (en) 2024-02-15
WO2023009293A2 (en) 2023-02-02
CN117882137A (zh) 2024-04-12
WO2023009293A3 (en) 2023-05-19
EP4367676A2 (en) 2024-05-15

Similar Documents

Publication Publication Date Title
MX353609B (es) Animales no humanos que expresan anticuerpos que tienen una cadena ligera comun.
MX353278B (es) Raton con cadena ligera comun.
GB202401655D0 (en) Antibody competition model using affinities of hidden variables
GB202012331D0 (en) Therapeutic antibodies
IL313760A (en) Human mouse models
EP2444414A4 (en) PEPTIDANTES FOR INDUCING ANTIBODIES FOR THE DETECTION OF THREE-DIMENSIONAL HIV STRUCTURES AND METHOD FOR THEIR SYNTHETIZATION
EP3037434A4 (en) COMPOSITION WITH A LIGHT CHAIN HUMAN ANTIBODY KAPPA COMPLEX AND METHOD FOR THE PRODUCTION THEREOF
CA238864S (en) Toy figure
GB201915144D0 (en) Method of promoting SCFA production by gut microbiota
CA216686S (en) Doll
CA214563S (en) Plush toy
PL430355A1 (pl) Sposób wytwarzania protez naczyniowych małych średnic
GB201903172D0 (en) Methods of deploying machine learning models
CA221982S (en) Toy stopwatch
CA226553S (en) Bracelet making toy
MX2014005196A (es) Modelo de citotoxidad celular dependiente de anticuerpos (adcc) in vivo.
CA191312S (en) Piece of construction set [toy]
CA191320S (en) Piece of construction set [toy]
CA191309S (en) Piece of construction set [toy]
CA191311S (en) Piece of construction set [toy]
CA191310S (en) Piece of construction set [toy]
CA191313S (en) Piece of construction set [toy]
CA191314S (en) Piece of construction set [toy]
CA191317S (en) Piece of construction set [toy]
CA220846S (en) Doll